Loading
J(
JBM (Healthcare) Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Sum Kwong Yip, Derek, was filed 19 Nov 2025.
JBM (Healthcare) Ltd.: what insiders have been doing
JBM (Healthcare) Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to HKEX. The last twelve months, up to 21 October 2026, brought 5 filings signed by 2 insiders.
On the market, 2 insiders bought (2 purchases) while 1 insider sold (1 sale totalling €1.3M). The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 2 senior executives among the declarants. One trade stands out by size: a sale of €1.3M from Sum Kwong Yip, Derek, disclosed on 23 January 2026.
Compared with its exchange (1,315 companies, median 4 filings), a count of 5 filings is above the norm. Over the whole record (from 2021), the tally stands at 61 purchases and 5 sales.
The most recent open-market purchase was published on 19 November 2025, 336 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. Until a filing is published, the market cannot know about the trade.
In the same sector, recent insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc also feature in our signals. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
79
Thresholds
n/a
Buy Volume
€24M
61 ops. · all time
Sell Volume
€1M
5 ops. · all time
Who traded when
BuySaleSum Kwong Yip, Derek3 buys1 sale
Yim Chun Leung2 buys
Since the insiders bought
- +81.6%Entry HK$1.52 · Close at T+365 HK$2.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 689 of 26,281 companies
82.7
score / 100
Value87
Quality78
FCF yld9.9%
Earn yld15%
EV/EBITDA5.4x
ROE18%
Gross mgn56%
Net mgn24%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
HK$1.60
Analyst consensus
Income statement
RevenueHK$834.6M
Gross profitHK$465.5M56% margin
EBITDAHK$313.6M38% margin
Net incomeHK$201.1M24.1% margin
Valuation
PER (trailing)6.4x
P/Book1.2x
Beta0.23
Balance sheet & cash
Market capHK$1.3B
Total debtHK$393.7M
Free Cash FlowHK$129.1M
Debt / Equity35%
Profitability & ownership
ROE18.3%
ROA10.0%
% insiders73.4%
% institutions0.3%
Last declaration on 23 January 2026
Declarations79 total
4,300,000 shares@ HK$2.805.2% of flowShareXHKGHKEX:DA20260123E00122
1,500,000 sharesShareXHKGHKEX:DA20260105E00210
600,000 sharesShareXHKGHKEX:DA20260105E00215
1,500,000 sharesShareXHKGHKEX:DA20251119E00154
Canonical exit: 16 Feb 2026 (T+90)
600,000 sharesShareXHKGHKEX:DA20251119E00152
Canonical exit: 16 Feb 2026 (T+90)
500,000 sharesShareXHKGHKEX:DA20250909E00176
2,800,000 sharesShareXHKGHKEX:DA20250801E00094
500,000 sharesShareXHKGHKEX:DA20250728E00359
Canonical exit: 26 Oct 2025 (T+90)
2,800,000 sharesShareXHKGHKEX:DA20250617E00287
Canonical exit: 15 Sept 2025 (T+90)
75,900,000 shares@ HK$2.1072.9% of flowShareXHKGHKEX:DA20250403E00252
Canonical exit: 2 Jul 2025 (T+90)
5,400,000 sharesShareXHKGHKEX:DA20240814E00152
5,400,000 sharesShareXHKGHKEX:DA20240703E00046
Canonical exit: 30 Sept 2024 (T+90)
2,900,000 sharesShareXHKGHKEX:DA20231121E00304
2,900,000 sharesShareXHKGHKEX:DA20231009E00338
Canonical exit: 4 Jan 2024 (T+90)
47,224,475 shares@ HK$0.5011.1% of flowShareXHKGHKEX:DA20230919E00283
Canonical exit: 13 Dec 2023 (T+90)
1,272 shares@ HK$0.770.0% of flowShareXHKGHKEX:DA20230914E00353
847,131 shares@ HK$0.83060.3% of flowShareXHKGHKEX:DA20230914E00316
9,268,890 sharesShareXHKGHKEX:DA20230828E00287
Canonical exit: 22 Nov 2023 (T+90)
25,450 sharesShareXHKGHKEX:DA20230828E00284
Canonical exit: 22 Nov 2023 (T+90)
300,728,143 sharesShareXHKGHKEX:DA20230828E00297
Canonical exit: 22 Nov 2023 (T+90)
492,259,244 sharesShareXHKGHKEX:DA20230828E00262
416,362 sharesShareXHKGHKEX:DA20230828E00266
Canonical exit: 22 Nov 2023 (T+90)
254,500 sharesShareXHKGHKEX:DA20230828E00282
Canonical exit: 22 Nov 2023 (T+90)
6,000,000 sharesShareXHKGHKEX:DA20230519E00179
3,268,000 shares@ HK$1.4282.1% of flowShareXHKGHKEX:DA20230413E00451
Canonical exit: 11 Jul 2023 (T+90)
25 of 79 declarations
About JBM (Healthcare) Ltd.
JBM (Healthcare) Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the healthcare sector. It focuses on the development and distribution of health-related products and services.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
